Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

China · Delayed Price · Currency is CNY

20.09

+0.25 (1.26%)

Aug 25, 2026, 10:05 AM CST

SHA:600671 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,416	2,108	1,069	1,420	1,158	1,094
Market Cap Growth	10.22%	97.15%	-24.70%	22.61%	5.90%	4.30%
Enterprise Value	2,594	2,298	1,174	1,451	1,262	1,178
Last Close Price	19.84	17.31	8.78	11.66	9.51	8.98

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	147.85	119.62	70.13	-	-	-
PS Ratio	11.85	9.96	4.92	11.66	10.63	7.44
PB Ratio	24.89	22.43	12.58	25.38	254.02	16.94
P/TBV Ratio	35.93	33.26	23.41	47.77	-	30.09
P/OCF Ratio	1199.69	178.78	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	12.72	10.85	5.40	11.92	11.59	8.01
EV/EBITDA Ratio	63.67	80.60	28.44	-	-	-
EV/EBIT Ratio	167.86	163.63	39.88	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	2.05	1.76	1.79	2.05	25.45	1.76
Debt / EBITDA Ratio	4.88	4.29	3.17	-	-	-
Net Debt / Equity Ratio	1.59	1.43	1.02	0.30	16.16	1.42
Net Debt / EBITDA Ratio	5.04	4.70	2.10	-1.47	-2.54	-4.67
Net Debt / FCF Ratio	-5.49	-6.91	-1.51	-0.57	-3.22	-2.94
Asset Turnover	0.46	0.48	0.55	0.38	0.31	0.35
Inventory Turnover	2.04	2.44	2.45	2.17	1.88	1.78
Quick Ratio	0.67	0.64	0.58	0.62	0.34	0.51
Current Ratio	0.84	0.81	0.78	0.82	0.56	0.74
Return on Equity (ROE)	7.98%	8.05%	31.02%	-129.89%	-211.59%	-41.52%
Return on Assets (ROA)	2.16%	1.99%	4.67%	-4.33%	-7.78%	-4.32%
Return on Invested Capital (ROIC)	4.11%	4.95%	18.13%	-29.84%	-37.48%	-16.44%
Return on Capital Employed (ROCE)	9.70%	8.80%	19.00%	-17.90%	-54.00%	-19.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.68%	0.84%	1.43%	-2.70%	-5.83%	-2.73%
FCF Yield	-1.16%	-0.92%	-5.35%	-2.07%	-1.98%	-2.85%
Payout Ratio	40.26%	36.87%	56.30%	-	-	-
Buyback Yield / Dilution	-0.01%	-0.01%	0.01%	0.00%	1.92%	-1.13%